Yaws medical therapy
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The mainstay of therapy for yaws is antimicrobial therapy. Pharmacologic therapy for yaws includes either Phenoxymethylpenicillin, Tetracyclines, Doxycycline, Erythromycin, or Azithromycin. Close contacts of patients must be examined and treated for yaws if the disease is present.
Medical therapy
- Yaws[1]
- Preferred regimen (1): Phenoxymethylpenicillin 12.5 mg/kg q6h 7-10days (maximum dose, 300 mg q6h)
- Preferred regimen (2): Tetracyclines 500 mg q6h 15 days or Doxycycline 100 mg q12h (alternative agents for the treatment of yaws in nonpregnant adults)
- Preferred regimen (3): Erythromycin 8–10 mg/kg 15 days q6h
- Preferred regimen (4): Azithromycin 30 mg/kg single-dose (maximum dose 2 g)
References
- ↑ Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL; et al. (2014). “Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America”. Clin Infect Dis. 59 (2): 147–59. doi:10.1093/cid/ciu296. PMID 24947530.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH